Blog

Dr. Kligman, A Board Certified ophthalmologist and fellowship-trained cornea, LASIK and cataract surgery specialist at SightMD was selected to serve on the Program Committee for the American Academy of Ophthalmology Annual Meeting.   For the second year in a row, Dr. Kligman will be a Reviewer for the Refractive Surgery section of the meeting, responsible for… Read More

Michael Savetsky, M.D. a board certified ophthalmologist at SightMD, recently traveled to Nhi Dong 2 Hospital in Ho Chi Minh City, Vietnam in December 2019 with the Doctors Abroad Foundation to volunteer in their Seventh Annual Medical Mission.  Doctors Abroad Foundation is a nonprofit whose purpose is to provide medical care to underprivileged families worldwide. … Read More

On January 15th, SightMD’s Dr. Lawrence Buono spoke to a large audience of Peconic Landing residents on Long Island’s North Fork about the importance of preventing and treating glaucoma and other age-related eye diseases, including macular degeneration, dry eye, and cataract surgery.  Dr. Buono’s well-received presentation, which coincides with Glaucoma Awareness month, has become an… Read More

January 13, 2020 – HAUPPAUGE, N.Y.—SightMD (or the “Company”), a multi-specialty ophthalmology platform, today announced a strategic partnership with Spencer E. Sherman, M.D., P.C., a Manhattan-based ophthalmology practice. Sight Growth Partners, the administrative services provider for SightMD, will also serve Dr. Sherman in all administrative manners. The acquisition represents SightMD’s third office in Manhattan, with… Read More

Hauppauge, NY – January 6, 2020 – SightMD (or the “Company”), a Sight Growth Partners managed practice and leading multi-specialty ophthalmology platform, today announced that it has hired retinal specialist Gaurav Chandra, M.D. to join its growing team of over 80 providers in the Tri-state area. Dr. Chandra is a fellowship-trained ophthalmologist specializing in medical… Read More

In an article written in Ocular Surgery News, Dr. Alanna Nattis summarized that before recommending a corneal transplant for keratoconus patients, corneal cross-linking should often be discussed and considered as a viable treatment for keratoconus patients of all ages with keratoconus due to its ability to halt or slow the progression of the disease. Keratoconus… Read More

In a co-authored press release, Dr. Alanna Nattis discussed the importance of achieving optimal refractive outcomes during cataract surgery carefully managing and executing limbal relaxing incisions and astigmatic keratotomies. She added that astigmatic keratotomies and limbal relaxing incisions alone or during cataract surgery provide today’s surgeons with a keystone procedure that improves patient quality of… Read More

In an article to help determine how bacteria within the Meibomian Glands influenced ocular surface disease, Dr. Nattis and her co-authors concluded that basic symptoms of the ocular surface disease do not necessarily correlate with clinical exam findings nor positive culture findings. They argued that the bacterial burden should be reconsidered as a direct risk… Read More

In an article published in Expert Opinion on Pharmacotherapy, Dr. Alanna Nattis outlined how the first medication approved in the United States for the treatment of signs and symptoms of Dry Eye Disease (Lifitegrast) fits into today’s treatment regime for Dry Eye Disease. Dr. Nattis pointed out that DED is a common ocular surface disorder that can… Read More

In an article published by ASCRS & ESCRS, Dr. Alanna Nattis discussed the outcomes achieved in a study with Keratoconus patients who were first treated with corneal cross-linking and followed up with a topography-guided PRK procedure.  Dr. Nattis reported that the participants reviewed patients who were diagnosed with keratoconus who had been treated with corneal cross-linking (CXL). After their CXL procedure,… Read More